$413.62
0.460.11%
At close: -
$415.00
1.380.33%
After Hours: Dec 24, 3:59 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for IDEXX Laboratories (IDXX) was reported on November 21, 2024 for the full year 2024. The company provided earnings per share guidance in the range of $10.37 to $10.53, compared to the estimated EPS of $10.52. Additionally, IDEXX Laboratories forecasted revenue between $3.87B and $3.89B for the quarter.
Browse guidance and forecast on all stocks.